Muñoz-Paz Javier, Jiménez-Jiménez Ana Belén, Espinosa-Rueda Francisco, Wahab-Albañil Amin, Muñoz-Alcaraz María Nieves, Peña-Amaro José, Mayordomo-Riera Fernando Jesús
Interlevel Clinical Management Unit of Physical Medicine and Rehabilitation, Reina Sofia University Hospital,-Cordoba and Guadalquivir Health District, 14011 Cordoba, Spain.
Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, 14004 Cordoba, Spain.
Clin Pract. 2025 Jul 26;15(8):141. doi: 10.3390/clinpract15080141.
: Adhesive capsulitis (AC) causes a global limitation of both active and passive range of motion (ROM) in the shoulder, with or without pain, and no specific radiographic findings. Its course is self-limiting and progresses through three or four stages. The diagnosis is primarily clinical, since imaging tests are nonspecific. Treatment options include physical therapy (PT), intra-articular corticosteroid injections, suprascapular nerve block (SSNB), and hydrodilatation (HD). The latter is useful for expanding and reducing inflammation of the joint capsule through the insufflation of saline solution, anesthetics, and corticosteroids. : To compare whether patients with AC, stratified by phase 1 and 2, who receive high-volume HD as treatment achieve better outcomes in terms of shoulder pain and function compared to patients who receive low-volume HD. To compare whether there are differences in PT times and to determine mean axillary recess (AR) values. : A randomized, parallel-block, triple-blind clinical trial will be conducted in 64 patients with AC in phases 1 and 2, aged 30 to 70 years, with limited active and passive ROM in two planes, and shoulder pain lasting more than 3 months. HD will be administered with volumes of 20 mL or 40 mL, followed by a conventional rehabilitation program. Outcomes will be reviewed at the 1st, 3rd, and 6th months of HD. Variables collected will include Shoulder Pain and Disability Index (SPADI), Visual Analog Scale (VAS), Range of motion (ROM), Lattinen index (LI), AR size, and time to completion of PT. : HD has been gaining clinical relevance in interventional rehabilitation as a treatment for AC, although its medium- and long-term efficacy remains a matter of debate. The variability in the volumes used for capsular expansion, with studies ranging from 18 mL to 47 mL, is compounded by the fact that most of these studies do not differentiate between AC stages. This could influence treatment effectiveness. Furthermore, diagnosis remains a challenge since valid and specific diagnostic parameters are lacking. : Understanding the differences between HD techniques, considering the influence of certain factors such as the volume used or the stages of AC, as well as improving diagnosis and the coordination of scientific work. This could facilitate the development of protocols for the use of HD in AC.
粘连性肩关节囊炎(AC)会导致肩部主动和被动活动范围(ROM)全面受限,伴或不伴疼痛,且无特异性影像学表现。其病程具有自限性,会历经三到四个阶段。诊断主要依靠临床判断,因为影像学检查不具有特异性。治疗选择包括物理治疗(PT)、关节内注射皮质类固醇、肩胛上神经阻滞(SSNB)和液压扩张(HD)。后者通过注入盐溶液、麻醉剂和皮质类固醇来扩张和减轻关节囊炎症,具有一定作用。
目的是比较1期和2期分层的AC患者接受大容量HD治疗与接受小容量HD治疗的患者在肩部疼痛和功能方面是否能取得更好的疗效。比较PT时间是否存在差异,并确定平均腋窝隐窝(AR)值。
将对64例年龄在30至70岁、1期和2期的AC患者进行一项随机、平行分组、三盲临床试验,这些患者在两个平面上主动和被动ROM受限,且肩部疼痛持续超过3个月。HD将分别以20 mL或40 mL的容量给药,随后进行常规康复计划。在HD治疗后的第1、3和6个月对结果进行评估。收集的变量将包括肩部疼痛和功能障碍指数(SPADI)、视觉模拟量表(VAS)、活动范围(ROM)、拉蒂宁指数(LI)、AR大小以及PT完成时间。
尽管HD作为AC的一种治疗方法在介入康复中的中长期疗效仍存在争议,但它在临床应用中越来越受到关注。用于关节囊扩张的容量存在差异,研究中的容量范围从18 mL到47 mL不等,而且大多数这些研究没有区分AC的阶段。这可能会影响治疗效果。此外,由于缺乏有效的特异性诊断参数,诊断仍然是一个挑战。
了解HD技术之间的差异,考虑诸如使用的容量或AC阶段等某些因素的影响,以及改善诊断和科研工作的协调性。这可能有助于制定AC中使用HD的方案。